Results 121 to 130 of about 3,748,215 (287)

A phenomap of TTR amyloidosis to aid diagnostic screening

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos   +4 more
wiley   +1 more source

Left atrial function in cardiac amyloidosis

open access: yes, 2016
Aims Left atrium can be involved by amyloid deposition in familial amyloid polyneuropathy (FAP). The aim of our study is to assess left atrium function in atrial amyloidosis.
Piccione M. C.   +25 more
core   +2 more sources

Early detection strain/strain rate and time to strain/strain rate abnormalities for left atrial mechanical function in hypertensive patients

open access: yes, 2019
Objective: To evaluate left atrial (LA) deformation parameters strain (S)/strain rate (SR) and time to peak S/SR obtained by two-dimensional speckle tracking echocardiography (2D-STE) in patients with hypertension for three LA mechanical phases and to ...
Yildiz, Cennet   +7 more
core   +1 more source

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén   +16 more
wiley   +1 more source

Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy - Fig 2

open access: yes, 2016
Maximal left atrial volume index (A) and global longitudinal strain (B) in young healthy control subjects, age- and sex-matched control subjects, overall hypertrophic cardiomyopathy patients, and each group of hypertrophic cardiomyopathy by the phenotype.
Joo-Hee Zo (721373)   +9 more
core   +1 more source

Study on the ultrasonic myocardial mechanics of left atrioventricular coupling in IBSH patients

open access: yesFrontiers in Cardiovascular Medicine
ObjectiveThis study aimed to evaluate the myocardial mechanical properties of the left atrium, left ventricle, and left atrioventricular coupling using ultrasound in patients with isolated basal septal hypertrophy (IBSH) caused by primary hypertension ...
Huimin Jia   +15 more
doaj   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer   +25 more
wiley   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Association of left atrial strain and stiffness index with ascending aortic dilatation in patients with bicuspid aortic valve

open access: yesFrontiers in Cardiovascular Medicine
BackgroundLeft atrial stiffness index (LASI) is an emerging echocardiographic index that reflects left atrial–left ventricular functional coupling and diastolic dysfunction.
Huan Liu   +8 more
doaj   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy